Breast Cancer Clinical Trials in Bologna
3 recruitingBologna, Italy
Showing 1–3 of 3 trials
Recruiting
Phase 3
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
Breast Cancer
Daiichi Sankyo250 enrolled86 locationsNCT05950945
Recruiting
Phase 3
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Breast Cancer
Greenwich LifeSciences, Inc.750 enrolled161 locationsNCT05232916
Recruiting
Not Applicable
Preoperative Boost Associated With Neoadjuvant Chemotherapy in Luminal B Breast Cancer
Breast CancerRadiotherapy
IRCCS Azienda Ospedaliero-Universitaria di Bologna30 enrolled1 locationNCT05673304